NCT01476592 2019-11-18
A Biological Study of Resveratrol's Effects on Notch-1 Signaling in Subjects With Low Grade Gastrointestinal Tumors
University of Wisconsin, Madison
Phase NA Completed
Clinical Trials
5 trialsNCT00920803 2017-06-14
A Clinical Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of SRT501 in Subjects With Colorectal Cancer and Hepatic Metastases
GlaxoSmithKline
Phase 1 Completed
NCT02261844 2017-03-30
Resveratrol and Human Hepatocyte Function in Cancer
University of Louisville
Phase 1/2 Withdrawn
NCT00433576 2014-09-15
Resveratrol in Treating Patients With Colorectal Cancer That Can Be Removed By Surgery
National Cancer Institute (NCI)
Phase 1 Completed
NCT00256334 2014-06-20
Resveratrol for Patients With Colon Cancer
University of California, Irvine
Phase 1 Completed